Trodusquemine: Phase I started

Genaera began a single-ascending dose, U.S. Phase I trial (Study 103) to evaluate 3, 6, 10 and 15 mg/m 2 dose levels of IV trodusquemine in 28 healthy overweight and obese volunteers. ...